Wholesaler of a wide range of products which include zyrop 4000 iu inj ( recombinant human erythropoietin alfa (4000iu) ), renocel 10000 mg inj ( recombinant human erythropoietin alfa (10000iu/ml) ) and renocel 4000 iu inj ( recombinant human erythropoietin alfa (4000iu/ml) ).
ZYROP 4000 IU INJ ( RECOMBINANT HUMAN ERYTHROPOIETIN ALFA (4000IU) )
Zyrop 4000 IU is a recombinant form of erythropoietin, a natural hormone responsible for stimulating red blood cell production in the body. It is commonly used to treat anemia associated with chronic kidney disease, cancer chemotherapy, or certain surgeries where blood loss may be a concern. Each 2 mL injection delivers 4000 IU of Erythropoietin Alfa and is administered either subcutaneously or intravenously under medical supervision. By enhancing the bone marrow’s ability to produce red blood cells, Zyrop helps reduce the need for blood transfusions and improves overall energy levels in patients with low hemoglobin. Treatment is typically tailored to individual response and may be used alongside iron therapy for better results. Zyrop provides an effective and clinically proven solution for managing anemia in patients with long-term health conditions.
RECOMBINANT HUMAN ERYTHROPOIETIN ALFA (10000IU/ML)
Treatment
Treats Anemia
Country of Origin
Made in India
Renocel 10000 IU Injection contains synthetic erythropoietin alfa, a bioengineered protein that encourages the bone marrow to produce more red blood cells. It is commonly administered via subcutaneous or intravenous injection under medical supervision to address anemia associated with chronic kidney disease, chemotherapy, HIV therapy, and preparation for certain surgeries. By restoring red blood cell counts, it helps alleviate fatigue, weakness, and oxygen deficiency symptoms. Typically given one to three times weekly, the dosage is personalized based on weight and underlying condition, and may be complemented by iron supplementation for enhanced effectiveness. Renocel must be refrigerated and brought to room temperature before use, ensuring convenience and safety for patients undergoing short-term or ongoing anemia treatment.
Request Callback
Yes! I am Interested
RENOCEL 4000 IU INJ ( RECOMBINANT HUMAN ERYTHROPOIETIN ALFA (4000IU/ML) )
Renocel 4000 IU Injection contains recombinant erythropoietin alfa, a bioengineered protein that stimulates the bone marrow to produce red blood cells. This treatment is indicated for managing anemia linked to chronic kidney disease, chemotherapy, HIV therapy, and to minimize transfusion requirements before surgery. Administered via subcutaneous or intravenous injection, the dosage is customized based on the patient’s weight and medical condition, often supplemented with iron therapy for enhanced effectiveness. Typically stored refrigerated and warmed to room temperature before use, Renocel is administered under medical supervision one to three times weekly. Its convenient dosing schedule supports improved hemoglobin levels, reduced fatigue, and better overall well-being, making it an essential option for adults seeking effective anemia management.